# Aurolife Pharma, LLC, Dayton, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/aurolife-pharma-llc/b82a0c8c-6b52-4624-8c6c-21887615bc7d

> Inspection records and compliance data for Aurolife Pharma, LLC in Dayton, New Jersey. 10 FDA inspections on record (1 OAI), 1 Form 483, 1 warning letter, last inspected December 07, 2021.

---

## Details

- Name: Aurolife Pharma, LLC
- FEI Number: 3005796917
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: 2400 US Highway 130
- City: Dayton
- State: New Jersey
- Zip Code: 08810
- Country Name: United States
- Address: 2400 US Highway 130, Dayton, New Jersey 08810, United States
- Country: United States

## Related Documents

- [483 - Aurolife Pharma, LLC - 2021-12-07](https://www.keypedia.com/records/483/aurolife-pharma-llc/c6b0115c-7a88-4138-8337-6f7454a491c3) — source: FDA, date: December 7, 2021
- [FDA Inspection 1158258 - Aurolife Pharma, LLC - 2021-12-07](https://www.keypedia.com/records/fda_inspections/aurolife-pharma-llc/b5941257-91bb-4441-8ba8-f35bfcc3ecea) — classification: Official Action Indicated (OAI), source: FDA, date: December 7, 2021
- 483 - Aurolife Pharma, LLC - 2020-02-12 — source: FDA, date: February 12, 2020
- [WARNING_LETTER - Aurolife Pharma, LLC - 2020-02-12](https://www.keypedia.com/records/warning_letter/aurolife-pharma-llc/8d5386ca-53df-44f7-9289-0337abcaf29f) — source: FDA, date: February 12, 2020
- [483 - Aurolife Pharma, LLC - 2019-10-22](https://www.keypedia.com/records/483/aurolife-pharma-llc/5b283c99-9b47-413e-9caf-15e27bb8a8bf) — source: FDA, date: October 22, 2019
- FDA Inspection 1109452 - Aurolife Pharma, LLC - 2019-10-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2019
- [FDA Inspection 1055912 - Aurolife Pharma, LLC - 2018-06-14](https://www.keypedia.com/records/fda_inspections/aurolife-pharma-llc/af02282b-baad-459c-ab27-5f81e3b9e7be) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2018
- FDA Inspection 980107 - Aurolife Pharma, LLC - 2016-07-28 — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2016
- FDA Inspection 952634 - Aurolife Pharma, LLC - 2016-01-12 — classification: No Action Indicated (NAI), source: FDA, date: January 12, 2016
- FDA Inspection 933659 - Aurolife Pharma, LLC - 2015-07-09 — classification: No Action Indicated (NAI), source: FDA, date: July 9, 2015
- FDA Inspection 851573 - Aurolife Pharma, LLC - 2013-10-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 15, 2013
- [FDA Inspection 752057 - Aurolife Pharma, LLC - 2011-11-02](https://www.keypedia.com/records/fda_inspections/aurolife-pharma-llc/2a993352-9a70-4eeb-a75e-ab898463b93c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 2, 2011
- [FDA Inspection 727943 - Aurolife Pharma, LLC - 2011-05-25](https://www.keypedia.com/records/fda_inspections/aurolife-pharma-llc/df9386a6-7efe-4aac-acde-70fa19ee80b2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 25, 2011
- FDA Inspection 581003 - Aurolife Pharma, LLC - 2009-05-11 — classification: No Action Indicated (NAI), source: FDA, date: May 11, 2009

## Related Companies

- [Genzyme Corporation](https://www.keypedia.com/companies/genzyme-corporation/f157f5fd-aee3-4994-b098-37af3a503a02)
- [Appco Pharma LLC](https://www.keypedia.com/companies/appco-pharma-llc/b4a77ba5-0e8a-47ae-94c2-951f5a0b2100)
- [Lannett Company LLC](https://www.keypedia.com/companies/lannett-company-llc/d4d7f04f-0ec5-4f5a-868b-d48963202cc8)
- [BioRamo, LLC](https://www.keypedia.com/companies/bioramo-llc/c32084c1-7762-45e7-aff6-b09ea6dfdf17)
- [Avantor Performance Materials LLC](https://www.keypedia.com/companies/avantor-performance-materials-llc/0621b513-0f0f-438c-8d52-81b548eb0501)
- [Frontage Laboratories, Inc.](https://www.keypedia.com/companies/frontage-laboratories-inc/1705f97d-14a3-4e46-b8a5-220bf2c4799f)
- [Hospira Australia Pty Ltd.](https://www.keypedia.com/companies/hospira-australia-pty-ltd/43f04346-c63c-4c33-92ed-a42abafdd533)
- [Sovereign Pharmaceuticals, LLC](https://www.keypedia.com/companies/sovereign-pharmaceuticals-llc/b8432227-cad1-4c55-91cc-a8c613f765fd)
- [Sharp Clinical Services, LLC](https://www.keypedia.com/companies/sharp-clinical-services-llc/d1817364-b3cb-41a2-818e-dea1083e5827)
- [Chartwell Pharmaceuticals LLC](https://www.keypedia.com/companies/chartwell-pharmaceuticals-llc/4a8c4844-be98-403a-8cb5-5fc90d592679)

## Related Officers

- [Advisor](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)
- [Yong Wu](https://www.keypedia.com/people/yong-wu/2ad66cf3-3491-447a-a962-9bab592d03d1)
- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)
- [District Director](https://www.keypedia.com/people/diana-amador-toro/66f3f6c5-4cfe-4f40-b4d4-d24ed4618e64)
- [Sanjay Singh](https://www.keypedia.com/people/sanjay-singh/e0b7a825-20ca-418a-9112-25dc58075d89)
